Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors

Jie Zhu; Chang Ming; Xin Fu; Yaou Duan; Duc Anh Hoang; Jeffrey Rutgard; Runze Zhang; Wenqiu Wang; Rui Hou; Daniel Zhang; Edward Zhang; Charlotte Zhang; Xiaoke Hao; Wenjun Xiong; Kang Zhang

doi:10.1038/cr.2017.57

Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors

Jie Zhu
, Chang Ming
, Xin Fu
, Yaou Duan
, Duc Anh Hoang
, Jeffrey Rutgard
, Runze Zhang
, Wenqiu Wang
, Rui Hou
, Daniel Zhang
, Edward Zhang
, Charlotte Zhang
, Xiaoke Hao^*
, Wenjun Xiong^*
, Kang Zhang^*

^*Corresponding author for this work

Department of Physics

Research output: Contribution to journal › Letter › peer-review

62 Citations (Scopus)

Original language	English
Pages (from-to)	830-833
Number of pages	4
Journal	Cell Research
Volume	27
Issue number	6
DOIs	https://doi.org/10.1038/cr.2017.57
Publication status	Published - Jun 2017

Access to Document

10.1038/cr.2017.57

Cite this

@article{b9503227ae0c420a8642ebf6b45ca61b,

title = "Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors",

author = "Jie Zhu and Chang Ming and Xin Fu and Yaou Duan and Hoang, \{Duc Anh\} and Jeffrey Rutgard and Runze Zhang and Wenqiu Wang and Rui Hou and Daniel Zhang and Edward Zhang and Charlotte Zhang and Xiaoke Hao and Wenjun Xiong and Kang Zhang",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2017. Funding Information: This study was funded by National Basic Research Program of China (973 Program) (2015CB964600, 2013CB967504), Hi-Tech Research and Development Program of China (863 Program) (2014AA021604), Hong Kong General Research Fund and Early Career Scheme (21105916) and Shenzhen Science and Technology Fund (JCYJ20160428155259007). Eye gene therapy consortium includes: Shaohua Yi, Jacqueline Pei, Suzi Zhu, Oulan Li (Shiley Eye Institute, University of California, San Diego), Guiqun Cao, Zhiguang Su (West China Hospital, Sichuan University), Tingshuai Jiang, Gen Li, Lianghong Zheng (Guangzhou KangRui Biological Pharmaceutical Technology Company). We thank Keiichiro Suzuki, Jun Wu, Prashant Mali, and all members of Kang Zhang{\textquoteright}s lab for critical discussion of the paper.",

year = "2017",

month = jun,

doi = "10.1038/cr.2017.57",

language = "English",

volume = "27",

pages = "830--833",

journal = "Cell Research",

issn = "1001-0602",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors

AU - Zhu, Jie

AU - Ming, Chang

AU - Fu, Xin

AU - Duan, Yaou

AU - Hoang, Duc Anh

AU - Rutgard, Jeffrey

AU - Zhang, Runze

AU - Wang, Wenqiu

AU - Hou, Rui

AU - Zhang, Daniel

AU - Zhang, Edward

AU - Zhang, Charlotte

AU - Hao, Xiaoke

AU - Xiong, Wenjun

AU - Zhang, Kang

N1 - Publisher Copyright: © The Author(s) 2017. Funding Information: This study was funded by National Basic Research Program of China (973 Program) (2015CB964600, 2013CB967504), Hi-Tech Research and Development Program of China (863 Program) (2014AA021604), Hong Kong General Research Fund and Early Career Scheme (21105916) and Shenzhen Science and Technology Fund (JCYJ20160428155259007). Eye gene therapy consortium includes: Shaohua Yi, Jacqueline Pei, Suzi Zhu, Oulan Li (Shiley Eye Institute, University of California, San Diego), Guiqun Cao, Zhiguang Su (West China Hospital, Sichuan University), Tingshuai Jiang, Gen Li, Lianghong Zheng (Guangzhou KangRui Biological Pharmaceutical Technology Company). We thank Keiichiro Suzuki, Jun Wu, Prashant Mali, and all members of Kang Zhang’s lab for critical discussion of the paper.

PY - 2017/6

Y1 - 2017/6

UR - https://www.scopus.com/pages/publications/85020219632

UR - https://doi.org/10.1038/s41422-019-0140-0

U2 - 10.1038/cr.2017.57

DO - 10.1038/cr.2017.57

M3 - Letter

C2 - 28429769

AN - SCOPUS:85020219632

SN - 1001-0602

VL - 27

SP - 830

EP - 833

JO - Cell Research

JF - Cell Research

IS - 6

ER -

Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors

Access to Document

Other files and links

Cite this